Biogen Advances Leading Research in Spinal Muscular Atrophy (SMA) with New Data at AAN 2021 Exploring Opportunities to Improve Outcomes for Patients

NEXT STORY
CERiS Offers First Prepayment Dual Reviews For Payment Integrity Programs
PREV STORY
Tonix Pharmaceuticals Enters into Exclusive Worldwide Licensing Agreement with OyaGen to Develop Antiviral SARS-CoV-2 Inhibitor, TNX-3500, for the Treatment of COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CB2 Insights 2019 Year In Review – A Message from CEO and Co-Founder Pradyum Sekar

author_avatar
NASDAQ Market News

Novo Nordisk A/S: Tresiba® demonstrates a safe cardiovascular profile and reduces the risk of severe hypoglycaemia compared to insulin glargine U100 in the DEVOTE trial

Bagsværd, 29 November 2016 - Today, Novo Nordisk announced the headline results from the ...

author_avatar
NASDAQ Market News

Basilea reports strong financial results for half-year 2020, progress in R&D portfolio and successful completion of strategic projects, despite COVID-19

author_avatar
NASDAQ Market News